Longitudinal assessment of the ultrasound gout lesions using the validated OMERACT semi-quantitative scoring system. c

Sara Nysom  Christiansen; Mikkel Østergaard; Ole Slot; Viktoria Fana; Lene Terslev

Longitudinal assessment of the ultrasound gout lesions using the validated OMERACT semi-quantitative scoring system. c

Sara Nysom Christiansen, Mikkel Østergaard, Ole Slot, Viktoria Fana, Lene Terslev

Afdeling for Rygkirurgi, Led- og Bindevævssygdomme

Abstract

Background In gout, ultrasound (US) is a promising tool to detect changes in monosodium urate (MSU) depositions during urate-lowering therapy (ULT). The OMERACT US group has developed definitions of gout-specific US lesions[1] and a semi-quantitative scoring system for US lesions representing MSU deposition (tophus, double contour (DC) and aggregates)[2], but the responsiveness of lesions when applying this scoring system has not yet been assessed.

Originalsprog	Engelsk
Publikationsdato	2022
Status	Udgivet - 2022
Begivenhed	EULAR 2022 - Copenhagen Varighed: 1 jun. 2022 → 4 jun. 2022

Konference

Konference	EULAR 2022
By	Copenhagen
Periode	01/06/2022 → 04/06/2022

Citationsformater

Longitudinal assessment of the ultrasound gout lesions using the validated OMERACT semi-quantitative scoring system. c. / Christiansen, Sara Nysom ; Østergaard, Mikkel; Slot, Ole et al.
2022. Annals of the Rheumatic Diseases Vol. 81, Issue Suppl 1 : 190 Abstract fra EULAR 2022, Copenhagen.

Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning › peer review

@conference{6b4a386e63a549d383984d85d716a21a,

title = "Longitudinal assessment of the ultrasound gout lesions using the validated OMERACT semi-quantitative scoring system. c",

abstract = "Background In gout, ultrasound (US) is a promising tool to detect changes in monosodium urate (MSU) depositions during urate-lowering therapy (ULT). The OMERACT US group has developed definitions of gout-specific US lesions[1] and a semi-quantitative scoring system for US lesions representing MSU deposition (tophus, double contour (DC) and aggregates)[2], but the responsiveness of lesions when applying this scoring system has not yet been assessed.",

author = "Christiansen, {Sara Nysom} and Mikkel {\O}stergaard and Ole Slot and Viktoria Fana and Lene Terslev",

note = "COPECARE; EULAR 2022 ; Conference date: 01-06-2022 Through 04-06-2022",

year = "2022",

language = "English",

pages = "Annals of the Rheumatic Diseases Vol. 81, Issue Suppl 1 : 190",

}

TY - ABST

T1 - Longitudinal assessment of the ultrasound gout lesions using the validated OMERACT semi-quantitative scoring system. c

AU - Christiansen, Sara Nysom

AU - Østergaard, Mikkel

AU - Slot, Ole

AU - Fana, Viktoria

AU - Terslev, Lene

N1 - COPECARE

PY - 2022

Y1 - 2022

N2 - Background In gout, ultrasound (US) is a promising tool to detect changes in monosodium urate (MSU) depositions during urate-lowering therapy (ULT). The OMERACT US group has developed definitions of gout-specific US lesions[1] and a semi-quantitative scoring system for US lesions representing MSU deposition (tophus, double contour (DC) and aggregates)[2], but the responsiveness of lesions when applying this scoring system has not yet been assessed.

AB - Background In gout, ultrasound (US) is a promising tool to detect changes in monosodium urate (MSU) depositions during urate-lowering therapy (ULT). The OMERACT US group has developed definitions of gout-specific US lesions[1] and a semi-quantitative scoring system for US lesions representing MSU deposition (tophus, double contour (DC) and aggregates)[2], but the responsiveness of lesions when applying this scoring system has not yet been assessed.

M3 - Conference abstract for conference

SP - Annals of the Rheumatic Diseases Vol. 81, Issue Suppl 1 : 190

T2 - EULAR 2022

Y2 - 1 June 2022 through 4 June 2022

ER -